The first artificial pancreas is being developed in the US DN style in a joint undertaking by Johnson & Johnson and the Juvenile Diabetes Research Foundation (JDRF).
Researchers hope that within the next four years, a first-generation system of the artificial organ will be available for review.
Initially, the system will be partially automated with a continuous glucose monitor and an insulin pump fitted to the patient's body in order to regulate glucose levels.
Libby Dowling, care advisor at Diabetes UK commented: "It is groundbreaking that one day an artificial pancreas, which would be a combination of an insulin pump and a continuous glucose sensor, could be developed to automatically regulate a person’s blood glucose levels."
She added that Diabetes UK is funding two similar projects at the University of Cambridge and hopes that similar technology will be developed in the UK.
More than 2.6 million people in the UK have been diagnosed with diabetes
while estimates show that a further half a million have the condition but are unaware of it.